XOMA CORP
XOMA Corp is a biotechnology company focused on developing therapeutic antibodies.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying XOMA's stock with a target price of $82.5, indicating strong growth potential.
Financial Health
XOMA CORP has a solid revenue and cash flow, indicating strong financial performance.
Dividend
XOMA Corp does not currently pay a dividend, which may indicate they are reinvesting profits for growth. If you invested $1000, you would not receive any dividends.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring XOMA
Intellectual Property
These companies own valuable ideas, brands, and inventions that generate reliable, contract-guaranteed income. Their asset-light business models create high-margin revenue streams without the costs of physical production, making them potential profit powerhouses across multiple industries.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Clinical Milestones Ahead
Progress or setbacks in trials and licensing milestones can sharply affect valuation, though outcomes are uncertain and can be binary.
Partner Collaborations
XOMA’s strategy relies on partnerships to advance and commercialise candidates, which can reduce development costs but add dependency on third parties.
Small‑cap Volatility
Market moves can be abrupt and driven by news; the stock may suit growth-focused investors who accept higher risk and financing uncertainty.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
